[Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease]

Arch Pediatr. 2013 Jul;20(7):762-7. doi: 10.1016/j.arcped.2013.04.013. Epub 2013 May 31.
[Article in French]

Abstract

Pain associated with vaso-occlusive crisis is the main cause of hospitalization in children with sickle cell disease. Recent studies have suggested that pain might have a neuropathic component. Lidocaine patches are commonly prescribed as a topical analgesic in adult neuropathic pain. This study reports the efficacy and safety of such treatment in 6 patients with sickle cell disease, aged 6-18 years, who had been hospitalized for vaso-occlusive crisis after failure of the standard analgesic treatment. These data have led to setting up a confirmatory phase II trial, which is currently underway.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Administration, Topical
  • Adolescent
  • Analgesia, Patient-Controlled
  • Analgesics, Opioid / therapeutic use
  • Anemia, Sickle Cell / drug therapy*
  • Anesthetics, Local / therapeutic use*
  • Child
  • Female
  • Humans
  • Lidocaine / therapeutic use*
  • Male
  • Morphine / therapeutic use
  • Pain Measurement

Substances

  • Analgesics, Opioid
  • Anesthetics, Local
  • Morphine
  • Lidocaine